Akzo Nobel Announces Preliminary Financial Results for 2017
Akzo Nobel recorded growth in the financial year 2017 in its sections decorative paints, particularly in Asia, and specialty chemicals. The costs of the transformation into a focused paints and coatings company, including the separation of specialty chemicals, is within expectations. The full-year and the fourth quarter 2017 report will be published on March 8, 2018.
The internal separation of the Specialty Chemicals business is complete. A full separation of Specialty Chemicals, either via a private sale or a legal demerger, remains on track for April 2018. As a result, the Specialty Chemicals business will be reported as discontinued operations.
Revenue, including discontinued operations, for full-year 2017 expected to be up 3% (up 4% excluding currency impact) at around €14,575 million (2016: €14,197 million)
EBIT, including discontinued operations, for full-year 2017 expected to be around €1,525 million (2016: €1,502 million). EBIT excludes identified items totaling around €130 million mainly related to the transformation of AkzoNobel into a focused Paints and Coatings company, including the separation of Specialty Chemicals.
Positive developments continued for Decorative Paints, particularly in Asia, while challenging conditions in the marine and oil and gas industries impacted Performance Coatings. Some industry specific headwinds persisted, including higher raw material costs, and adverse effects from foreign currency increased further. Continuous improvement and cost discipline contributed positively to achieving the results.
Specialty Chemicals delivered a strong performance throughout 2017, including during the fourth quarter. AkzoNobel also confirms financial guidance for 2020: Paints and Coatings 15% ROS, ROI >25%; Specialty Chemicals 16% ROS, ROI >20%, reflecting continued growth in profitability.
Transformation within expectations
The transformation of AkzoNobel into a focused Paints and Coatings company, including the separation of Specialty Chemicals, is progressing well and the associated one-off costs are within expectations. Phase one of creating a fit for purpose Paints and Coatings organization, announced in October 2017, is on track to achieve €110 million savings in 2018, contributing directly towards delivering the 2020 financial guidance. Various measures to mitigate current market challenges, including increased selling prices and cost discipline, also continue to be implemented.
As previously announced, AkzoNobel will publish a report for the full-year and the fourth quarter 2017 on Thursday, March 8, 2018. This is later than previous years due to the financial reporting process relating to the separation of Specialty Chemicals.
OPSC Resumes PTA Production
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
$1.35 Billion! AkzoNobel to Sell Decorative Paints Business in Southeast Asia and Australia to Nippon Paint
-
China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber
-
$25 Billion Paint Giant Born: AkzoNobel and Axalta Shareholders Approve Merger by Landslide
-
Nippon Paint Offers $8.55 Billion for AkzoNobel’s Decorative Paints Business
-
Unable to Buy Entire AkzoNobel, Nippon Paint Begins a "Disassembled Approach"
-
AkzoNobel Rejects €12.5 Billion Offer from Nippon Paint and Sherwin-Williams, Sticks to Merger with Axalta
-
Record Net Profit, Yet “Joining Forces” with a Rival? Axalta Drops a Final Trump Card Before the Merger
-
AkzoNobel Invests €50 Million to Expand Aerospace Coatings Operations in the United States
-
AkzoNobel Completes Sale of AkzoNobel India Limited to JSW Group
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal
Recommend Reading
-
Wanhua Chemical’s “Tale of Two Cities”: 850,000 Tonnes Isn’t Capacity—It’s a Declaration of War
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Celanese Sells 19% Nutrinova Stake for $152 Million; Mitsui & Co. Raises Holding to 89% to Complete Upstream Integration
-
Business Society’s Melamine Trend Analysis on September 18, 2026: Moderate Correction
-
Business Society September 22, 2026 Maleic Anhydride Trend Analysis: Volatility
-
Business Society’s Ethanol Trend Analysis for September 18, 2026: Volatile Consolidation
-
Business Society September 22, 2026 Propylene Oxide Trend Analysis: Clear Decline
-
Business Society’s Acetone Trend Analysis for September 18, 2026: Narrow-Range Adjustment